Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Two Palonosetron Formulations in Healthy Volunteers
NCT04585412Phase 4Completed
- Sponsor
- Yung Shin Pharmaceutical Industry
- Start
- Aug 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of palonosetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by Yung Shin Pharmaceutical Industry. Started Aug 2020; status: completed.
02
Drugs
palonosetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT04585412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04585412.